Viewing StudyNCT06378892



Ignite Creation Date: 2024-05-06 @ 8:25 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06378892
Status: RECRUITING
Last Update Posted: 2024-04-23
First Post: 2024-04-10

Brief Title: A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer NSCLC With Exclusively Extracranial Disease Progression on Lorlatinib
Sponsor: Centro di Riferimento Oncologico - Aviano
Organization: Centro di Riferimento Oncologico - Aviano

Conditions & Keywords Data

Conditions:
Name
ALK Gene Mutation
Non Small Cell Lung Cancer Metastatic
Keywords: